Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on July 2, 2025

MT Newswires

a day ago

Vertex Pharmaceuticals Says European Commission Approves Alyftrek for Treating Cystic Fibrosis

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire

a day ago

Vertex Announces European Commission Approval of ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis

AbbVie to buy Capstan for up to $2.1 billion in immunology push

Reuters

2 days ago

AbbVie to buy Capstan for up to $2.1 billion in immunology push

Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?

Zacks

2 days ago

Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock?

H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results

Insider Monkey

3 days ago

H.C. Wainwright Reaffirms Vertex Buy Rating After ADA Conference Results

Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug

Insider Monkey

5 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Benefited from the Launch of its New Drug

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call

StockStory

6 days ago

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

Zacks

7 days ago

CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?

Vertex Pharmaceuticals Presents “Unprecedented” Data for T1D Cell Therapy Zimislecel, Shows Durable Benefit

Insider Monkey

8 days ago

Vertex Pharmaceuticals Presents “Unprecedented” Data for T1D Cell Therapy Zimislecel, Shows Durable Benefit

Clinical Trials Arena

9 days ago

Vertex presents data from Phase I/II stage of trial for type 1 diabetes

MT Newswires

9 days ago

Vertex Pharmaceuticals, Ono Sign License Deal for Povetacicept in Japan, South Korea

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

Business Wire

9 days ago

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions

Business Wire

11 days ago

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions

Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

Zacks

12 days ago

Here's Why Vertex Pharmaceuticals (VRTX) Fell More Than Broader Market

Vertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake

Insider Monkey

12 days ago

Vertex (VRTX) Stock PT Lowered to $420 on slower Alyftrek Uptake

MT Newswires

12 days ago

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $460 From $464

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

13 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

Zacks

13 days ago

Can Casgevy Deliver a Turnaround for CRISPR Therapeutics?

2 Growth Stocks to Buy and Hold for 10 Years

Motley Fool

13 days ago

2 Growth Stocks to Buy and Hold for 10 Years

MT Newswires

15 days ago

RBC Capital Adjusts PT on Vertex Pharmaceuticals to $420 From $423, Maintains Sector Perform Rating

Exploring High Growth Tech Stocks In The US This June 2025

Simply Wall St.

16 days ago

Exploring High Growth Tech Stocks In The US This June 2025

3 Stocks Estimated To Be Trading At A Discount Of Up To 48.1%

Simply Wall St.

16 days ago

3 Stocks Estimated To Be Trading At A Discount Of Up To 48.1%

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Motley Fool

16 days ago

3 Growth Stocks You Can Buy Right Now Without Any Hesitation

Vertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should Know

Zacks

19 days ago

Vertex Pharmaceuticals (VRTX) Stock Moves -1.00%: What You Should Know

Vertex Presents New Data on the Benefits of ALYFTREK

Insider Monkey

20 days ago

Vertex Presents New Data on the Benefits of ALYFTREK

1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore

StockStory

22 days ago

1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore

Vertex Pharmaceuticals (NasdaqGS:VRTX) Highlights Clinical Benefits Of ALYFTREK At Cystic Fibrosis Conference

Simply Wall St.

25 days ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Highlights Clinical Benefits Of ALYFTREK At Cystic Fibrosis Conference

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference

Business Wire

a month ago

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference

Why Is Apellis Pharmaceuticals (APLS) Up 7.2% Since Last Earnings Report?

Zacks

a month ago

Why Is Apellis Pharmaceuticals (APLS) Up 7.2% Since Last Earnings Report?

Cytokinetics (CYTK) Down 1.9% Since Last Earnings Report: Can It Rebound?

Zacks

a month ago

Cytokinetics (CYTK) Down 1.9% Since Last Earnings Report: Can It Rebound?

Vertex (VRTX) Down 0.8% Since Last Earnings Report: Can It Rebound?

Zacks

a month ago

Vertex (VRTX) Down 0.8% Since Last Earnings Report: Can It Rebound?

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks

a month ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

3 No-Brainer Healthcare Stocks to Buy in June

Motley Fool

a month ago

3 No-Brainer Healthcare Stocks to Buy in June

2 Top Stocks to Buy Right Now

Motley Fool

a month ago

2 Top Stocks to Buy Right Now

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

StockStory

a month ago

Q1 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics Stocks

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Motley Fool

a month ago

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

StockStory

a month ago

Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1

3 Top Growth Stocks to Buy in the Second Half of 2025

Motley Fool

a month ago

3 Top Growth Stocks to Buy in the Second Half of 2025

2 Monster Growth Stocks to Buy and Hold for 10 Years

Motley Fool

a month ago

2 Monster Growth Stocks to Buy and Hold for 10 Years

MT Newswires

a month ago

Argus Adjusts Price Target on Vertex Pharmaceuticals to $525 From $550

Argus Research

a month ago

Analyst Report: Vertex Pharmaceuticals, Inc.

Argus Research

a month ago

Market Digest: AIG, HST, PSA, VRTX

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

Motley Fool

a month ago

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

Motley Fool

a month ago

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?

VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss

StockStory

a month ago

VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss

The Top Corporate Board Directors

The Wall Street Journal

a month ago

The Top Corporate Board Directors

Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.

Motley Fool

a month ago

Warren Buffett Remains Optimistic About America. Here Are Top American Companies Worth Investing In.

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.

2 months ago

Exploring High Growth Tech Stocks in the US Market

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Motley Fool

2 months ago

Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

StockStory

2 months ago

Q1 Therapeutics Earnings: United Therapeutics (NASDAQ:UTHR) Impresses

2 Biotech Stocks That Are Screaming Buys in May

Motley Fool

2 months ago

2 Biotech Stocks That Are Screaming Buys in May

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Motley Fool

2 months ago

This Stock Just Dropped by 12% in 1 Day. History Says This Will Happen Next

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Motley Fool

2 months ago

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Motley Fool

2 months ago

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?

Insider Monkey

2 months ago

Is Vertex Pharmaceuticals (VRTX) Among the Best Stocks to Buy According to Jim Simons’ Renaissance Technologies?

My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Motley Fool

2 months ago

My Favorite Tariff Safe-Haven Stock to Buy on the Dip

Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment

Insider Monkey

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Simply Wall St.

2 months ago

Vertex Pharmaceuticals Incorporated Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

4 No-Brainer Stocks to Buy Right Now

Motley Fool

2 months ago

4 No-Brainer Stocks to Buy Right Now

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

StockStory

2 months ago

Unpacking Q1 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks

Viatris’ new form of old pain drug scores in large trials

BioPharma Dive

2 months ago

Viatris’ new form of old pain drug scores in large trials

VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations

Zacks

2 months ago

VRTX Stock Down as Q1 Sales of New Drugs Miss Expectations

MT Newswires

2 months ago

Wolfe Research Downgrades Vertex Pharmaceuticals to Peer Perform From Outperform

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

Motley Fool

2 months ago

Why Vertex Pharmaceuticals Stock Is a Screaming Buy on the Dip

1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore

StockStory

2 months ago

1 S&P 500 Stock with Impressive Fundamentals and 2 to Ignore

Morningstar Research

2 months ago

Analyst Report: Vertex Pharmaceuticals Incorporated

Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash

The Wall Street Journal

2 months ago

Stocks to Watch Recap: Palantir, Ford, Mattel, DoorDash

S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop

Investopedia

2 months ago

S&P 500 Gains & Losses Today: Stocks Fall for Second Day as Palantir, Pharmaceuticals Drop

Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Investor's Business Daily

2 months ago

Vertex Pharmaceuticals Topples 10% On A Series Of First-Quarter Setbacks

Rising Costs Weigh on Vertex Q1 Earnings

Motley Fool

2 months ago

Rising Costs Weigh on Vertex Q1 Earnings

MT Newswires

2 months ago

Barclays Adjusts Vertex Pharmaceuticals Price Target to $499 From $467, Maintains Equal Weight Rating

MT Newswires

2 months ago

RBC Raises Price Target on Vertex Pharmaceuticals to $423 From $420, Keeps Sector Perform Rating

MT Newswires

2 months ago

Morgan Stanley Lifts Price Target on Vertex Pharmaceuticals to $464 From $462, Keeps Equalweight Rating

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Vertex Pharmaceuticals Inc Earnings Call

MT Newswires

2 months ago

Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $575 From $550, Maintains Buy Rating

MT Newswires

2 months ago

Morgan Stanley Adjusts Price Target on Vertex Pharmaceuticals to $464 From $462, Maintains Equalweight Rating

MT Newswires

2 months ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $515 From $512, Maintains Overweight Rating

Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now

Motley Fool

2 months ago

Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now

3 No-Brainer Stocks to Buy in May

Motley Fool

2 months ago

3 No-Brainer Stocks to Buy in May

5 Growth Stocks to Buy in May and Go Away

Motley Fool

2 months ago

5 Growth Stocks to Buy in May and Go Away

Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow

StockStory

2 months ago

Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Outperforms Broader Market: What You Need to Know

What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings

Zacks

2 months ago

What Analyst Projections for Key Metrics Reveal About Vertex (VRTX) Q1 Earnings

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for

Zacks

2 months ago

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for

Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?

Zacks

2 months ago

Vertex Gears Up to Report Q1 Earnings: Is a Beat in the Cards?

Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

My 5 Top Stocks to Buy Right Now in This Highly Volatile Market

Motley Fool

2 months ago

My 5 Top Stocks to Buy Right Now in This Highly Volatile Market

Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks

The Wall Street Journal

2 months ago

Wall Street’s New Tariff Safe Haven: High-Tax Biotech Stocks

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

Zacks

2 months ago

CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards?

Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts

Zacks

2 months ago

Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts

Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds

Pharmaceutical Technology

2 months ago

Top 20 biopharmas’ market cap rises 6% in Q1 2025 amid tariff headwinds

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

2 months ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

Motley Fool

2 months ago

Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

Motley Fool

2 months ago

3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

2 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right

Motley Fool

2 months ago

Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right

Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Simply Wall St.

2 months ago

Vertex Pharmaceuticals (NasdaqGS:VRTX) Faces UK Patent Lawsuit Over Groundbreaking CASGEVY Therapy

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

Motley Fool

2 months ago

Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next

MT Newswires

2 months ago

BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $557 From $545

Share on Social Networks: